AKT1 and cancer: Additionally, KEGG pathway enrichment analysis showed that “MicroRNAs in cancer” and “Phosphatidylinositol 3-kinase/protein kinase B (PI3K-AKT) signaling pathway” comprised the largest number of targets (Fig. 2C).